Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer
I Meattini, M Guenzi, A Fozza, C Vidali, P Rovea… - Breast Cancer, 2017 - Springer
Conservative management of breast cancer represents the standard treatment for early disease.
Breast conserving surgery associated with radiotherapy for stage I-II has been proven to …
Breast conserving surgery associated with radiotherapy for stage I-II has been proven to …
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside
…, N Lorito, C Becherini, M Bacci, L Visani, A Fozza… - Cancer treatment …, 2022 - Elsevier
Major advances have been made in precision medicine of breast cancer patients with a series
of molecular targeted therapies now in clinical use or in late clinical development. These …
of molecular targeted therapies now in clinical use or in late clinical development. These …
Current radiotherapy techniques in NSCLC: challenges and potential solutions
…, A Bruni, P Ciammella, F Cuccia, A Fozza… - Expert Review of …, 2020 - Taylor & Francis
Introduction: Radiotherapy is an important therapeutic strategy in the management of non-small
cell lung cancer (NSCLC). In recent decades, technological implementations and the …
cell lung cancer (NSCLC). In recent decades, technological implementations and the …
[HTML][HTML] A real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage III non-small …
…, S Cozzi, E D'Angelo, N Giaj Levra, A Fozza… - Frontiers in …, 2021 - frontiersin.org
Introduction For unresectable stage III non-small cell lung cancer (NSCLC), the standard
therapy consists of chemoradiotherapy (CRT) followed by durvalumab maintenance for …
therapy consists of chemoradiotherapy (CRT) followed by durvalumab maintenance for …
Once-weekly hypofractionated whole-breast radiotherapy after breast-conserving surgery in older patients: a potential alternative treatment schedule to daily 3-week …
P Rovea, A Fozza, P Franco, C De Colle… - Clinical breast …, 2015 - Elsevier
Background The purpose of this study was to retrospectively report clinical outcomes on a
consecutive series of older early breast cancer patients treated with once-weekly adjuvant …
consecutive series of older early breast cancer patients treated with once-weekly adjuvant …
Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform
…, J Dognini, L Donadoni, S Falivene, A Fozza… - Acta …, 2017 - Taylor & Francis
Aim: To quantify the variability between radiation oncologists (ROs) when outlining axillary
nodes in breast cancer. Material and methods: For each participating center, three ROs with …
nodes in breast cancer. Material and methods: For each participating center, three ROs with …
Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group
F Gregucci, A Fozza, S Falivene, D Smaniotto… - La radiologia …, 2020 - Springer
Aims To investigate the present attitude of the Italian Radiation Oncologists in the
management of breast cancer (BC) concerning hypofractionated radiotherapy (hRT), partial-breast …
management of breast cancer (BC) concerning hypofractionated radiotherapy (hRT), partial-breast …
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: evidence for excellent feasibility and favorable outcomes
…, F Cavagnetto, D Bosetti, A Fozza… - Reports of Practical …, 2017 - journals.viamedica.pl
Background The present report provides preliminary outcomes with intraoperative radiotherapy
delivered to women with breast cancer included in a re-irradiation program. Materials …
delivered to women with breast cancer included in a re-irradiation program. Materials …
Technological advancements and future perspectives in breast cancer radiation therapy
A Fozza, F De Rose, MC De Santis… - Expert Review of …, 2023 - Taylor & Francis
Introduction Breast cancer is still one of the most common tumors worldwide and radiation
therapy has a central role in the oncological pathway. Several technological options are now …
therapy has a central role in the oncological pathway. Several technological options are now …
Radiotherapy in patients with HIV: current issues and review of the literature
Although the introduction of highly active antiretroviral therapy has radically improved the
life expectancy of patients with HIV, HIV positivity is still considered a major barrier to …
life expectancy of patients with HIV, HIV positivity is still considered a major barrier to …